HEADER TRANSFERASE 22-AUG-22 8E5R TITLE SCHISTOSOMA MANSONI (BLOOD FLUKE) SULFOTRANSFERASE/CIDD-0150610 TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: SULFOTRANSFERASE OXAMNIQUINE RESISTANCE PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCHISTOSOMA MANSONI; SOURCE 3 ORGANISM_TAXID: 6183; SOURCE 4 GENE: SULT-OR, SMP_089320; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PAG8H KEYWDS SULFOTRANSFERASE, PARASITE, DRUG RESISTANCE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.B.TAYLOR,S.N.ALWAN REVDAT 1 26-JUL-23 8E5R 0 JRNL AUTH S.N.ALWAN,A.B.TAYLOR,J.RHODES,M.TIDWELL,S.F.MCHARDY, JRNL AUTH 2 P.T.LOVERDE JRNL TITL OXAMNIQUINE DERIVATIVES OVERCOME PRAZIQUANTEL TREATMENT JRNL TITL 2 LIMITATIONS FOR SCHISTOSOMIASIS. JRNL REF PLOS PATHOG. V. 19 11018 2023 JRNL REFN ESSN 1553-7374 JRNL PMID 37428793 JRNL DOI 10.1371/JOURNAL.PPAT.1011018 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.84 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 58966 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.390 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 53.8400 - 3.3700 0.93 4153 145 0.1523 0.1909 REMARK 3 2 3.3700 - 2.6800 1.00 4254 150 0.1808 0.1856 REMARK 3 3 2.6800 - 2.3400 1.00 4191 148 0.1679 0.1645 REMARK 3 4 2.3400 - 2.1300 0.89 3747 131 0.1550 0.2011 REMARK 3 5 2.1300 - 1.9700 0.85 3518 124 0.1576 0.2140 REMARK 3 6 1.9700 - 1.8600 1.00 4136 144 0.1614 0.2078 REMARK 3 7 1.8600 - 1.7600 1.00 4153 147 0.1617 0.2035 REMARK 3 8 1.7600 - 1.6900 1.00 4135 145 0.1696 0.2386 REMARK 3 9 1.6900 - 1.6200 1.00 4118 144 0.1829 0.2182 REMARK 3 10 1.6200 - 1.5700 1.00 4127 145 0.1923 0.2056 REMARK 3 11 1.5700 - 1.5200 1.00 4112 145 0.2248 0.2697 REMARK 3 12 1.5200 - 1.4700 1.00 4094 143 0.2652 0.3264 REMARK 3 13 1.4700 - 1.4400 1.00 4127 145 0.2898 0.3463 REMARK 3 14 1.4400 - 1.4000 1.00 4101 144 0.3199 0.3598 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.173 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.904 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.74 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 2257 REMARK 3 ANGLE : 1.247 3081 REMARK 3 CHIRALITY : 0.084 344 REMARK 3 PLANARITY : 0.006 380 REMARK 3 DIHEDRAL : 15.054 846 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8E5R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000267896. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59038 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 140.890 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6BDR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MCSG-3 CONDITION A1: 20% PEG 8000, 0.1 REMARK 280 M HEPES:NAOH PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 70.44450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.83400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 70.44450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 19.83400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 713 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 257 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 91 174.20 74.23 REMARK 500 VAL A 127 -42.55 -131.25 REMARK 500 ASN A 150 -168.10 -116.35 REMARK 500 ASN A 228 30.99 75.12 REMARK 500 ASP A 255 39.60 -95.51 REMARK 500 REMARK 500 REMARK: NULL DBREF 8E5R A 1 257 UNP G4VLE5 G4VLE5_SCHMA 1 257 SEQADV 8E5R GLY A -1 UNP G4VLE5 EXPRESSION TAG SEQADV 8E5R ALA A 0 UNP G4VLE5 EXPRESSION TAG SEQRES 1 A 259 GLY ALA MET ILE GLU SER SER THR THR ILE GLN VAL ILE SEQRES 2 A 259 SER ALA GLY LEU PRO ARG THR GLY THR LYS SER LEU LYS SEQRES 3 A 259 ASN ALA LEU GLU ILE ILE TYR HIS LYS PRO CYS TYR HIS SEQRES 4 A 259 MET PHE GLU ILE ILE PHE ASN LYS GLN SER ASP ILE ILE SEQRES 5 A 259 LYS TRP GLN ASN LEU ILE HIS ASP SER HIS MET ILE THR SEQRES 6 A 259 THR PRO PRO PRO LEU THR THR LYS THR ILE ALA ILE TYR SEQRES 7 A 259 ASP LYS LEU LYS GLU LEU LEU ASP GLY TYR ILE ALA THR SEQRES 8 A 259 THR ASP LEU PRO THR CYS GLY PHE TYR LYS ASP LEU MET SEQRES 9 A 259 ASN ILE TYR PRO ASN ALA LYS VAL LEU LEU THR ILE ARG SEQRES 10 A 259 ASP LYS TYR ASP TRP LEU HIS SER LEU ARG LYS VAL VAL SEQRES 11 A 259 LEU PRO LYS SER ASN ASP PRO TRP LYS LEU LYS ILE GLU SEQRES 12 A 259 GLU GLY ASP LYS VAL LEU GLY LEU ASN SER ASP PHE TYR SEQRES 13 A 259 LYS LEU THR GLU ASP SER LEU LYS PHE ALA PHE GLN LYS SEQRES 14 A 259 ASP ASP LEU ASN PHE ASP ASP ASP GLN VAL LEU LEU GLU SEQRES 15 A 259 CYS TYR ASP GLU TYR ASN ARG LEU VAL GLN GLU THR VAL SEQRES 16 A 259 PRO SER ASP ARG LEU LEU VAL LEU ARG LEU GLY ASP GLY SEQRES 17 A 259 TRP GLU PRO LEU CYS LYS PHE LEU ASN VAL GLU ILE PRO SEQRES 18 A 259 ASN GLY ILE ASP TYR PRO CAS VAL ASN SER HIS HIS GLN SEQRES 19 A 259 MET THR GLN LEU THR GLU GLN LEU ILE LYS TYR LYS SER SEQRES 20 A 259 LEU ASP ALA ILE ILE HIS MET PHE PRO ASP LEU ILE MODRES 8E5R CAS A 226 CYS MODIFIED RESIDUE HET CAS A 226 18 HET ULX A 401 39 HET A3P A 402 27 HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETNAM ULX [4-({[(3R)-1-[(1H-INDOL-3-YL)METHYL]-3-{[4- HETNAM 2 ULX (TRIFLUOROMETHYL)PHENYL]METHYL}PYRROLIDIN-3- HETNAM 3 ULX YL]METHYL}AMINO)-3-NITROPHENYL]METHANOL HETNAM A3P ADENOSINE-3'-5'-DIPHOSPHATE FORMUL 1 CAS C5 H12 AS N O2 S FORMUL 2 ULX C29 H31 F3 N4 O3 FORMUL 3 A3P C10 H15 N5 O10 P2 FORMUL 4 HOH *222(H2 O) HELIX 1 AA1 GLY A 19 HIS A 32 1 14 HELIX 2 AA2 HIS A 37 LYS A 45 1 9 HELIX 3 AA3 ASP A 48 SER A 59 1 12 HELIX 4 AA4 HIS A 60 ILE A 62 5 3 HELIX 5 AA5 THR A 69 LEU A 83 1 15 HELIX 6 AA6 THR A 94 GLY A 96 5 3 HELIX 7 AA7 PHE A 97 TYR A 105 1 9 HELIX 8 AA8 ASP A 116 VAL A 128 1 13 HELIX 9 AA9 ASP A 134 LEU A 147 1 14 HELIX 10 AB1 ASN A 150 GLN A 166 1 17 HELIX 11 AB2 ASP A 174 VAL A 193 1 20 HELIX 12 AB3 PRO A 194 ASP A 196 5 3 HELIX 13 AB4 GLY A 206 ASN A 215 1 10 HELIX 14 AB5 SER A 229 LYS A 244 1 16 HELIX 15 AB6 ILE A 249 PHE A 253 5 5 SHEET 1 AA1 5 CYS A 35 TYR A 36 0 SHEET 2 AA1 5 ALA A 88 THR A 89 1 O ALA A 88 N TYR A 36 SHEET 3 AA1 5 VAL A 10 SER A 12 1 N SER A 12 O THR A 89 SHEET 4 AA1 5 LYS A 109 ILE A 114 1 O LYS A 109 N ILE A 11 SHEET 5 AA1 5 LEU A 198 ARG A 202 1 O LEU A 201 N LEU A 112 LINK C PRO A 225 N ACAS A 226 1555 1555 1.33 LINK C PRO A 225 N BCAS A 226 1555 1555 1.33 LINK C ACAS A 226 N VAL A 227 1555 1555 1.23 LINK C BCAS A 226 N VAL A 227 1555 1555 1.22 CISPEP 1 PRO A 65 PRO A 66 0 -0.52 CISPEP 2 PRO A 66 PRO A 67 0 -15.77 CISPEP 3 LEU A 92 PRO A 93 0 0.77 CRYST1 140.889 39.668 53.839 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007098 0.000000 0.000000 0.00000 SCALE2 0.000000 0.025209 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018574 0.00000